VRTX
Vertex Pharmaceuticals Inc
508.30$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +257.9% | +50.3% | +23.5% | +107.3% | -18.7% | +56.2% | -14.3% | -113.9% | – | |
| – | -1.4% | -1.5% | 0.0% | +18.0% | +47.7% | +2.4% | +14.7% | +18.1% | +22.3% | +14.3% | +1.3% | |
| – | +30.1% | +2.9% | +22.3% | +11.8% | +10.9% | +19.1% | +2.8% | +11.3% | +18.3% | +20.2% | -1.8% | |
| – | +37.3% | +0.3% | +226.9% | -51.7% | -0.8% | +36.5% | -13.2% | -1.6% | – | – | – | |
| – | – | – | – | +1,459.4% | -127.8% | – | – | – | -178.0% | – | – | |
| – | -11.5% | +24.9% | +358.6% | -63.2% | -21.0% | +244.3% | -9.5% | -12.9% | +26.2% | +15.2% | +47.0% | |
| – | +263.5% | -61.1% | -519.0% | -53.8% | +511.1% | – | -443.0% | -5.8% | +878.4% | +20.0% | -74.9% | |
| – | – | – | – | – | -51.8% | +2,537.3% | -61.5% | – | – | – | – | |
| – | -32.4% | -63.2% | +405.4% | -201.5% | -45.1% | +285.1% | +111.2% | -89.0% | +148.6% | +175.3% | +71.4% | |
| – | -98.7% | -356.9% | +2,882.4% | -97.5% | +394.0% | -17.1% | -15.9% | +250.4% | -47.5% | -25.2% | -83.9% | |
| – | -62.0% | -29.5% | -48.7% | -204.1% | – | -498.6% | +192.5% | -95.4% | +730.4% | +165.9% | +51.3% | |
| – | +60.0% | +424.2% | +2.6% | +105.8% | -53.3% | +520.2% | -71.7% | +357.6% | -103.8% | – | – | |
| – | – | – | +226.1% | +100.6% | +27.2% | +100.4% | -19.5% | +63.0% | -16.5% | -124.1% | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.